Sonya MacVicar

Sonya MacVicar

Auto-generated profile, based on publicly available information

Sonya MacVicar

Associate Professor, School of Health and Social Care, Edinburgh Napier University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Pediatrics
Verified
Journal Article
Closed access
PDF file
LKLauren Kelly
Lauren Kelly
FSFlora Shan
Flora Shan
SMSonya MacVicar
Sonya MacVicar
ECEmily Czaplinksi
Emily Czaplinksi
WMWendy Moulsdale
Wendy Moulsdale
MOMartin Offringa
Martin Offringa
BACKGROUND: As rates of neonatal opioid withdrawal are increasing, the need for research to evaluate new treatments is growing. Large heterogeneity exists in health outcomes reported in current literature. Our objective is to develop an evidence-informed and consensus-based core outcome set in neonatal opioid withdrawal syndrome (NOWS-COS) for use in studies and clinical practice. METHODS: An international multidisciplinary steering committee was established. A systematic review and a 3-round Delphi was performed with open-ended and score-based assessments of the importance of each outcome to inform clinical management of neonatal opioid withdrawal. Interviews were conducted with parents and/or caregivers on outcome importance. Finally, a consensus meeting with diverse stakeholders was held to review all data from all sources and establish a core set of outcomes with definitions. RESULTS: The NOWS-COS was informed by 47 published studies, 41 Delphi participants, and 6 parent interviews. There were 63 outcomes evaluated. Final core outcomes include (1) pharmacologic treatment, (2) total dose of opioid treatment, (3) duration of treatment, (4) adjuvant therapy, (5) feeding difficulties, (6) consolability, (7) time to adequate symptom control, (8) parent-infant bonding, (9) duration of time the neonate spent in the hospital, (10) breastfeeding, (11) weight gain at hospital discharge, (12) readmission to hospital for withdrawal, and (13) neurodevelopment. CONCLUSIONS: We developed an evidence-informed and consensus-based core outcome set. Implementation of this core outcome set will reduce heterogeneity between studies and facilitate evidence-based decision-making. Future research will disseminate all the findings and pilot test the validity of the NOWS-COS in additional countries and populations to increase generalizability and impact.

7 February 2018 in Birth
Verified
Journal Article
Open access
PDF file
SMSonya MacVicar
Sonya MacVicar
THTracy Humphrey
Tracy Humphrey
KFKatrina Forbes-McKay
Katrina Forbes-McKay
Background: Breastfeeding rates are typically low for women with a substance‐use disorder. This is despite the specific benefits of breastfeeding to alleviate the severity of neonatal abstinence syndrome and the well‐documented generic advantages. This study explored the feasibility of in‐hospital, tailored breastfeeding support for the substance‐exposed mother and baby.Methods: This was a mixed‐methods feasibility study undertaken in Scotland from April 2014 to May 2015. Women with a substance‐use disorder either received standard Baby‐Friendly Initiative care only or were given additional support which included a dedicated breastfeeding support worker, personalized capacity‐building approach, and a low‐stimuli environment for 5 days. Feasibility outcome measures were maternal recruitment, satisfaction and acceptability of support, breastfeeding on fifth postnatal day, and severity of neonatal abstinence syndrome.Results: Fourteen mother‐infant dyads participated. Intervention participants demonstrated higher rates of continued breastfeeding and reported a greater degree of satisfaction with support and confidence in their breastfeeding ability. Maternal experience of health care practices, attitudes, and postnatal environment influenced their perceptions of breastfeeding support. Breastfed infants were less likely to require pharmacotherapy for neonatal withdrawal and had a shorter hospital stay.Conclusions: The findings highlight the feasibility of tailored breastfeeding support for the substance‐exposed mother and baby and endorse the promotion and support of breastfeeding for this group. Future research should include a statistically powered randomized controlled trial to evaluate clinical efficacy.

1 February 2021 in Women and Birth
Verified
Journal Article
Closed access
GMGill Moncrieff
Gill Moncrieff
SMSonya MacVicar
Sonya MacVicar
GNGail Norris
Gail Norris
CMCaroline J. Hollins Martin
Caroline J. Hollins Martin

2 April 2019 in Birth
Verified
Journal Article
Closed access
PDF file
SMSonya MacVicar
Sonya MacVicar
LKLauren E. Kelly
Lauren E. Kelly

23 October 2019 in Journal of Advanced Nursing
Verified
Journal Article
Closed access
PDF file
RHRobin Hyde
Robin Hyde
SMSonya MacVicar
Sonya MacVicar
THTracy Humphrey
Tracy Humphrey

10 August 2015 in Birth
Verified
Journal Article
Closed access
PDF file
SMSonya MacVicar
Sonya MacVicar
PKPamela Kirkpatrick
Pamela Kirkpatrick
THTracy Humphrey
Tracy Humphrey
KFKatrina Forbes-McKay
Katrina Forbes-McKay